2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the …
2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Guidelines for the management of acute coronary syndromes Developed by the task force on …
Prevalence of statin intolerance: a meta-analysis
Aims Statin intolerance (SI) represents a significant public health problem for which precise
estimates of prevalence are needed. Statin intolerance remains an important clinical …
estimates of prevalence are needed. Statin intolerance remains an important clinical …
不稳定性心绞痛和非ST 段抬高心肌梗死诊断与治疗指南
柯元南， 陈纪林 - 中华心血管病杂志, 2007 - cqvip.com
近年来, 对不稳定性心绞痛(unstable angina, UA) 和非ST 段抬高心肌梗死(non-ST-elevation
myocardial infarction, NSTEMI) 病理生理机制的认识逐步深入, 有关大规模临床试验结果陆续 …
myocardial infarction, NSTEMI) 病理生理机制的认识逐步深入, 有关大规模临床试验结果陆续 …
[HTML][HTML] Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
Background Statin therapy is effective for the prevention of atherosclerotic cardiovascular
disease and is widely prescribed, but there are persisting concerns that statin therapy might …
disease and is widely prescribed, but there are persisting concerns that statin therapy might …
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal …
RM Cooper‐DeHoff, M Niemi… - Clinical …, 2022 - Wiley Online Library
Statins reduce cholesterol, prevent cardiovascular disease, and are among the most
commonly prescribed medications in the world. Statin‐associated musculoskeletal …
commonly prescribed medications in the world. Statin‐associated musculoskeletal …
Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes …
AJ Garber, Y Handelsman, G Grunberger, D Einhorn… - Endocrine Practice, 2020 - Elsevier
ABSTRACT Abbreviations: A1C= hemoglobin A1C; AACE= American Association of Clinical
Endocrinologists; ABCD= adiposity-based chronic disease; ACCORD= Action to Control …
Endocrinologists; ABCD= adiposity-based chronic disease; ACCORD= Action to Control …
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …
JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome
K Kimura, T Kimura, M Ishihara, Y Nakagawa… - Circulation …, 2019 - jstage.jst.go.jp
Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …
Association between achieved low-density lipoprotein cholesterol levels and long-term cardiovascular and safety outcomes: an analysis of FOURIER-OLE
P Gaba, ML O'Donoghue, JG Park, SD Wiviott, D Atar… - Circulation, 2023 - Am Heart Assoc
Background: Low-density lipoprotein cholesterol (LDL-C) is a well-established risk factor for
atherosclerotic cardiovascular disease. However, the optimal achieved LDL-C level with …
atherosclerotic cardiovascular disease. However, the optimal achieved LDL-C level with …
Pleiotropic effects of statins on the cardiovascular system
A Oesterle, U Laufs, JK Liao - Circulation research, 2017 - Am Heart Assoc
The statins have been used for 30 years to prevent coronary artery disease and stroke. Their
primary mechanism of action is the lowering of serum cholesterol through inhibiting hepatic …
primary mechanism of action is the lowering of serum cholesterol through inhibiting hepatic …